NCT00096057View on ClinicalTrials.gov

Monoclonal Antibody HuHMFG1 in Treating Women With Locally Advanced or Metastatic Breast Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 31, 2004

Study Completion Date

December 31, 2007

Conditions
Breast Cancer
Interventions
BIOLOGICAL

monoclonal antibody HuHMFG1

Trial Locations (3)

80045

University of Colorado Cancer Center at UC Health Sciences Center, Aurora

90095-1781

Jonsson Comprehensive Cancer Center at UCLA, Los Angeles

77030-4009

M.D. Anderson Cancer Center at University of Texas, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Jonsson Comprehensive Cancer Center

OTHER

NCT00096057 - Monoclonal Antibody HuHMFG1 in Treating Women With Locally Advanced or Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter